These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26790476)

  • 1. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.
    Lemckert FA; Bournazos A; Eckert DM; Kenzler M; Hawkes JM; Butler TL; Ceely B; North KN; Winlaw DS; Egan JR; Cooper ST
    Cardiovasc Res; 2016 May; 110(2):178-87. PubMed ID: 26790476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MG53 participates in ischaemic postconditioning through the RISK signalling pathway.
    Zhang Y; Lv F; Jin L; Peng W; Song R; Ma J; Cao CM; Xiao RP
    Cardiovasc Res; 2011 Jul; 91(1):108-15. PubMed ID: 21285295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.
    Waddell LB; Lemckert FA; Zheng XF; Tran J; Evesson FJ; Hawkes JM; Lek A; Street NE; Lin P; Clarke NF; Landstrom AP; Ackerman MJ; Weisleder N; Ma J; North KN; Cooper ST
    J Neuropathol Exp Neurol; 2011 Apr; 70(4):302-13. PubMed ID: 21412170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.
    Wu HK; Zhang Y; Cao CM; Hu X; Fang M; Yao Y; Jin L; Chen G; Jiang P; Zhang S; Song R; Peng W; Liu F; Guo J; Tang L; He Y; Shan D; Huang J; Zhou Z; Wang DW; Lv F; Xiao RP
    Circulation; 2019 Feb; 139(7):901-914. PubMed ID: 30586741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MG53 constitutes a primary determinant of cardiac ischemic preconditioning.
    Cao CM; Zhang Y; Weisleder N; Ferrante C; Wang X; Lv F; Zhang Y; Song R; Hwang M; Jin L; Guo J; Peng W; Li G; Nishi M; Takeshima H; Ma J; Xiao RP
    Circulation; 2010 Jun; 121(23):2565-74. PubMed ID: 20516375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage.
    Feng H; Shen H; Robeson MJ; Wu YH; Wu HK; Chen GJ; Zhang S; Xie P; Jin L; He Y; Wang Y; Lv F; Hu X; Zhang Y; Xiao RP
    Diabetes; 2022 Feb; 71(2):298-314. PubMed ID: 34844991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MG53 anchored by dysferlin to cell membrane reduces hepatocyte apoptosis which induced by ischaemia/reperfusion injury in vivo and in vitro.
    Yao W; Li H; Han X; Chen C; Zhang Y; Tai WL; Xia Z; Hei Z
    J Cell Mol Med; 2017 Oct; 21(10):2503-2513. PubMed ID: 28401647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H
    Shan D; Guo S; Wu HK; Lv F; Jin L; Zhang M; Xie P; Wang Y; Song Y; Wu F; Lan F; Hu X; Cao CM; Zhang Y; Xiao RP
    Circulation; 2020 Sep; 142(11):1077-1091. PubMed ID: 32677469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
    Cai C; Weisleder N; Ko JK; Komazaki S; Sunada Y; Nishi M; Takeshima H; Ma J
    J Biol Chem; 2009 Jun; 284(23):15894-902. PubMed ID: 19380584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.
    Liu J; Zhu H; Zheng Y; Xu Z; Li L; Tan T; Park KH; Hou J; Zhang C; Li D; Li R; Liu Z; Weisleder N; Zhu D; Lin P; Ma J
    J Mol Cell Cardiol; 2015 Mar; 80():10-19. PubMed ID: 25533937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MG53: Biological Function and Potential as a Therapeutic Target.
    Zhang Y; Wu HK; Lv F; Xiao RP
    Mol Pharmacol; 2017 Sep; 92(3):211-218. PubMed ID: 28432201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
    Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair.
    Wang X; Xie W; Zhang Y; Lin P; Han L; Han P; Wang Y; Chen Z; Ji G; Zheng M; Weisleder N; Xiao RP; Takeshima H; Ma J; Cheng H
    Circ Res; 2010 Jul; 107(1):76-83. PubMed ID: 20466981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MG53: A new protagonist in the precise treatment of cardiomyopathies.
    Zhao Q; Zhang Q; Zhao X; Tian Z; Sun M; He L
    Biochem Pharmacol; 2024 Apr; 222():116057. PubMed ID: 38367817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking MG53
    Lv F; Wang Y; Shan D; Guo S; Chen G; Jin L; Zheng W; Feng H; Zeng X; Zhang S; Zhang Y; Hu X; Xiao RP
    Circ Res; 2022 Dec; 131(12):962-976. PubMed ID: 36337049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair.
    Lek A; Evesson FJ; Lemckert FA; Redpath GM; Lueders AK; Turnbull L; Whitchurch CB; North KN; Cooper ST
    J Neurosci; 2013 Mar; 33(12):5085-94. PubMed ID: 23516275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MG53 is a double-edged sword for human diseases.
    Zhang Y; Wu HK; Lv FX; Xiao RP
    Sheng Li Xue Bao; 2016 Aug; 68(4):505-16. PubMed ID: 27546510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.
    Li Z; Dai R; Chen M; Huang L; Zhu K; Li M; Zhu W; Li Y; Xie N; Li J; Wang L; Lan F; Cao CM
    Cardiovasc Res; 2023 Nov; 119(14):2421-2440. PubMed ID: 37527538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle.
    Philouze C; Turban S; Cremers B; Caliez A; Lamarche G; Bernard C; Provost N; Delerive P
    PLoS One; 2021; 16(2):e0245179. PubMed ID: 33566837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.